Abstract RF2-02: Pooled analysis of the BrighTNess, CALGB 40603 (Alliance), and GeparSixto clinical trials identifies the impact of neoadjuvant carboplatin on pCR and survival in early-stage triple-negative breast cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: B. M. Felsheim, V. Nekljudova, L. A. Carey, J. Huober, A. Schneeweiss, S. M. Tolaney, M. Untch, C. S. Kuzma, A. Fernandez-Martinez, S. Rachakonda, R. Suresh, D. G. Stover, P. Rastogi, M. Darsow, D. E. Lake, H. S. Rugo, J. O’Shaughnessy, M. Golshan, A. D. Pfefferle, W. M. Sikov, O. Metzger, C. Denkert, C. E. Geyer, C. M. Perou, S. Loibl
Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Kantonsspital St. Gallen, German Cancer Research Center, National Center for Tumor Diseases, Dana-Farber Cancer Institute, Helios Hospital Berlin-Buch, Southeast Clinical Oncology Research Consortium, FirstHealth of the Carolinas, Institut Gustave Roussy, Washington University in St. Louis, The Ohio State University, University of Pittsburgh, Luisenkrankenhaus, Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, City of Hope, Baylor University Medical Center, Yale University, Brown University, Women & Infants Hospital of Rhode Island, Philipps University of Marburg
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129464041